The F4/AS01(B) HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial

The impact of the investigational human immunodeficiency virus type 1 (HIV-1) F4/AS01(B) vaccine on HIV-1 viral load (VL) was evaluated in antiretroviral therapy (ART)-naive HIV-1 infected adults. This phase IIb, observer-blind study (NCT01218113), included ART-naive HIV-1 infected adults aged 18 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinges, Warren, Girard, Pierre-Marie, Podzamczer, Daniel, Brockmeyer, Norbert H., García, Felipe., Harrer, Thomas, Lelievre, Jean-Daniel, Frank, Ian, Colin De Verdière, Nathalie, Yeni, Guy-Patrick, Ortega Gonzalez, Enrique, Rubio, Rafael, Clotet Sala, Bonaventura, DeJesus, Edwin, Pérez-Elias, Maria Jesus, Launay, Odile, Pialoux, Gilles, Slim, Jihad, Weiss, Laurence, Bouchaud, Olivier, Felizarta, Franco, Meurer, Anja, Raffi, François, Esser, Stefan, Katlama, Christine, Koletar, Susan L., Mounzer, Karam, Swindells, Susan, Baxter, John D., Schneider, Stefan, Chas, Julie, Molina, Jean-Michel, Koutsoukos, Marguerite, Collard, Alix, Bourguignon, Patricia, Roman, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753889/
https://www.ncbi.nlm.nih.gov/pubmed/26871794
http://dx.doi.org/10.1097/MD.0000000000002673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753889/
https://www.ncbi.nlm.nih.gov/pubmed/26871794
http://dx.doi.org/10.1097/MD.0000000000002673

Ejemplares similares